Ultragenyx Pharmaceutical (RARE) Earnings Date, Estimates & Call Transcripts $39.30 +0.33 (+0.85%) Closing price 05/2/2025 04:00 PM EasternExtended Trading$40.50 +1.20 (+3.05%) As of 05:15 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Ultragenyx Pharmaceutical Earnings Summary Upcoming Earnings DateMay. 6Before Market OpensEstimatedConsensus EPS (Feb. 13) -$1.32 Actual EPS (Feb. 13) -$1.39 Missed By -$0.07 Actual Revenue (Feb. 13) $164.88MUltragenyx Pharmaceutical announced Q4 2024 earnings on February 13, 2025, reporting an EPS of -$1.39, which missed analysts' consensus estimates of -$1.32 by $0.07. Quarterly revenue was reported to be $164.88 million, above analyst estimates of $163.23 million. With a trailing EPS of -$6.34, Ultragenyx Pharmaceutical's earnings are expected to grow next year, from ($5.18) to ($3.22) per share. Q4 2024 Earnings ResourcesQ4 2024 Earnings ReportConference Call Transcript & Audio Annual Report (10-K) Slide Deck Press Release (8-K)RARE Upcoming EarningsUltragenyx Pharmaceutical's Q1 2025 earnings is scheduled for Tuesday, May 6, 2025, with a conference call scheduled at 5:00 PM ET. Check back for transcripts, audio, and key financial metrics as they become available.Q1 2025 Earnings ReportSlide DeckFull Screen Slide DeckPowered by Get Ultragenyx Pharmaceutical Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Ultragenyx Pharmaceutical and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataRARE Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.RARE Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ultragenyx Pharmaceutical Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateRevenue EstimateCompany Revenue GuidanceQ1 20253-$1.39-$1.09-$1.23Q2 20253-$1.32-$1.02-$1.15Q3 20253-$1.27-$0.86-$1.05Q4 20253-$1.18-$0.82-$0.99 FY 2025 12 -$5.16 -$3.79 -$4.42 Q1 20261-$0.36-$0.36-$0.36Q2 20261-$0.23-$0.23-$0.23Q3 20261-$0.19-$0.19-$0.19Q4 20261-$0.03-$0.03-$0.03 Ultragenyx Pharmaceutical Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 5/6/2025(Estimated)-------2/13/2025Q4 2024-$1.32-$1.39 -$0.07-$1.39$163.23M$164.88M11/5/2024Q3 2024-$1.45-$1.40+$0.05-$1.40$135.28M$139.49M8/1/2024Q2 2024-$1.64-$1.52+$0.12-$1.52$123.20M$147.03M5/2/2024Q1 2024-$1.72-$2.03 -$0.31-$2.03$116.03M$108.83M2/15/2024Q4 2023-$1.65-$1.52+$0.13-$1.52$119.38M$127.39M11/2/2023Q3 2023-$2.08-$2.23 -$0.15-$2.23$99.38M$98.05M8/3/2023Q2 2023-$2.11-$2.25 -$0.14-$2.25$107.10M$108.30M Ultragenyx Pharmaceutical Earnings - Frequently Asked Questions When is Ultragenyx Pharmaceutical's earnings date? Ultragenyx Pharmaceutical has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, May 6th, 2025 based off last year's report dates. Learn more on RARE's earnings history. What guidance has Ultragenyx Pharmaceutical issued on next quarter's earnings? Ultragenyx Pharmaceutical updated its FY 2025 earnings guidance on Tuesday, March, 4th. The company issued revenue guidance of $640.0 million-$670.0 million, compared to the consensus revenue estimate of $651.9 million. Did Ultragenyx Pharmaceutical beat their earnings estimates last quarter? In the previous quarter, Ultragenyx Pharmaceutical (NASDAQ:RARE) missed the analysts' consensus estimate of ($1.32) by $0.07 with a reported earnings per share (EPS) of ($1.39). Learn more on analysts' earnings estimate vs. RARE's actual earnings. How can I listen to Ultragenyx Pharmaceutical's earnings conference call? The conference call for Ultragenyx Pharmaceutical's latest earnings report can be listened to online. Listen to Conference Call How can I read Ultragenyx Pharmaceutical's conference call transcript? The conference call transcript for Ultragenyx Pharmaceutical's latest earnings report can be read online. Read Transcript How much revenue does Ultragenyx Pharmaceutical generate each year? Ultragenyx Pharmaceutical (NASDAQ:RARE) has a recorded annual revenue of $560.23 million. How much profit does Ultragenyx Pharmaceutical generate each year? Ultragenyx Pharmaceutical (NASDAQ:RARE) has a recorded net income of -$569.18 million. RARE has generated -$6.34 earnings per share over the last four quarters. What is Ultragenyx Pharmaceutical's EPS forecast for next year? Ultragenyx Pharmaceutical's earnings are expected to grow from ($5.18) per share to ($3.22) per share in the next year. More Earnings Resources from MarketBeat Related Companies ITCI Earnings GMAB Earnings RDY Earnings MRNA Earnings ASND Earnings VTRS Earnings QGEN Earnings ROIV Earnings RVMD Earnings LNTH Earnings Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Amazon Earnings: 2 Reasons to Love It, 1 Reason to Be CautiousMeta Takes A Bow With Q1 Earnings - Watch For Tariff Impact in Q2Palantir Earnings: 1 Bullish Signal and 1 Area of ConcernVisa Q2 Earnings Top Forecasts, Adds $30B Buyback PlanMicrosoft Crushes Earnings, What’s Next for MSFT Stock?Qualcomm's Earnings: 2 Reasons to Buy, 1 to Stay AwayAMD Stock Signals Strong Buy Ahead of Earnings This page (NASDAQ:RARE) was last updated on 5/5/2025 by MarketBeat.com Staff From Our PartnersElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredTrump’s Bitcoin Reserve is No Accident…Bryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new b...Crypto 101 Media | SponsoredShocking AI play that’s beats Nvidia by a country mileYou’ve seen the headlines about Nvidia. Now Tim Sykes is sounding the alarm — because what CEO Jensen Huang is...Timothy Sykes | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredDonald Trump is about to free crypto from its chains …Sure enough, Bitcoin took off on the exact day Juan said it would. It's up more than 40% since the election...Weiss Ratings | SponsoredElon Set to Shock the World on June 1st?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ultragenyx Pharmaceutical Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Ultragenyx Pharmaceutical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy RARE Stock Free RARE Stock Alerts